Increase in the geriatric and pediatric patients is escalating the growth of the sugar-based excipients pharmaceuticals market

 

Sugar-based Excipients Market

Sugar-based excipients are chemical substances that replace sugar with another substance, which serves as a vehicle for transporting a medicinal or therapeutic ingredient. Sugar-based pharmaceuticals are widely used for the treatment of diabetes and to prevent the absorption of glucose from the gastrointestinal tract into the bloodstream. Common sugar-based pharmaceuticals are lactose, glycerin, propionyl, and glycine. They are commonly used in topical gels, lip balms, cough syrup, oral supplements, vaginal suppositories, intravenous medications, oral supplements, nasal sprays, oral antibiotics, topical analgesics, and intravenous fluids. The sugar-based pharmaceutical is also utilized for the absorption of estrogen by the body and it’s binding with progestin for the prevention of uterine cancer.

The increasing use of co-processed excipients in the pharmaceutical industry is augmenting the growth of sugar-based excipients market. The rise in a number of geriatric and pediatric patients is again driving the growth of the market. This is creating demand for a wide-range of syrups and tablets is also projected to propel the growth of the sugar-based excipients market. Sugar-based excipients are majorly used in the manufacturing of antibiotics and syrup formulation. Growing demand for various tablets such as vitamins and many tablets for pediatric use that contain almost 50% sugar is again expected to foster the growth of the market. The rapidly growing generic sector due to patent expiry is further projected to foster the growth of the sugar-based excipients market.

North America is projected to gain significant growth over the forecast period and this is attributed to the increasing pharmaceutical industry in the region due to growing spending by regional players and government. According to the Pharmapproach Limited, the United States in 2018 was the largest pharmaceutical market, generating about $484.8 billion which represented 40.4% of the $1.2 trillion generated worldwide. This was over $350 billion more than any other country. Also, increasing consumer spending on medicine is further projected to propel the regional market growth. It is projected that by 2023, Americans would spend between $635 and $655 billion on medicine.

Key Developments:

1.   1.   In October 2020, MEGGLE Excipients & Technology (MEGGLE) has developed Reta M®. The first hypromellose/mannitol-based, co-processed excipient specifically designed for direct compression (DC) and dry granulation of modified release formulations for the pharmaceutical and nutraceutical market

2.   2.   In January 2018, Colorcon Inc. announces the development of sugar-coated pharmaceutical tablets with the launch of Opadry® SGR, Rapid Sugar Film Coating System. This new aqueous system delivers a more streamlined application process


Comments

Popular posts from this blog

Fitness Equipment Market is doing warm-ups to pull growth-rich opportunities from the growing obesity rates accompanied by the sedentary lifestyles

The market for ureteral stents would benefit from the rising prevalence of urological diseases

Increased Prevalence of Chronic Diseases and Stem Cell Therapy R&D to Drive Stem Cell Assay Market Growth